ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Transcranial Magnetic Stimulation for the Treatment of Phantom Pain

This study has been completed.

Sponsored by: National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001923
  Purpose

Phantom pain refers to the sensation of pain felt by patients who have had a limb amputated. The treatment of phantom pain is often disappointing and is unable to provide adequate relief to the patients. The area of the brain involved (posterior parietal cortex [PPC]) is found on the opposite side of the amputated limb. For example, if a patient has the right arm amputated, the left posterior parietal cortex is involved in the phantom pain.

Researchers believe that if they can decrease activity in the posterior parietal cortex they may be able to reduce phantom pain.

Researchers plan to use low frequency (1 Hz) transcranial magnetic stimulation (TMS) to decrease the excitability of the PPC opposite the side of the amputated limb. TMS involves the placement of a cooled electromagnet with a figure-eight coil on the patient's scalp and turning on the magnetic flux. This permits non-invasive, relatively localized stimulation of the surface of the brain (cerebral cortex). When an area of the brain is stimulated a period follows when that area cannot be stimulated again. In this case, researchers plan to use TMS to stimulate the PPC in order to decrease the level of excitability there.


Condition Intervention Phase
Pain
Procedure: Transcranial magnetic stimulation
Phase I

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Safety Study
Official Title:   Phantom Pain: A Therapeutic Trial Using Transcranial Magnetic Stimulation

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   20
Study Start Date:   December 1998
Estimated Study Completion Date:   December 2002

Detailed Description:

Phantom pain is a chronic painful condition that affects patients with amputations. Treatment for phantom pain is often disappointing. In amputees, hyperexcitability of the posterior parietal cortex area (PPC) contralateral to the side of the amputation has been linked with the presence of phantom sensations. PPC is an area overactive in different forms of chronic pain too. It is therefore conceivable that downregulation of activity in PPC could improve phantom limb pain, a condition poorly responsive to available treatments. We have previously demonstrated that low frequency TMS (1 Hz) results in decreased excitability of the stimulated cortical regions. We plan to apply low-frequency TMS to PPC cortical areas contralateral to the side of the amputated limb. We expect that this intervention will result in amelioration of the phantom pain. Stimulation of the PPC area (target intervention) will be compared with a control intervention in which TMS is directed slightly away from the head.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Patients must be between 18 and 65 years of age.

Patients must have amputations and phantom pain for at least 12 months.

Patient's pain should be at least moderate and be present at least 8 hours per day or severe lasting for at least 2 hours per day.

Patients must not have had a previous stroke or brain lesions.

Patients must not have severe depression, poor motivational capacity.

Patients must not have serious cognitive deficits (defined as equivalent to a mini-mental state exam score of 20 or less).

Patients must not have severe uncontrolled medical problems (e.g. cardiovascular disease, any kind of end-stage pulmonary or cardiovascular disease, or epilepsy).

Patients must not have a personal history of seizures or other neurological disorders.

Women must not be pregnant.

Patients must not have severe coronary disease.

Patients must not have metal in the cranium except mouth.

Patients must not have intracardiac lines.

Patients must not have increased intracranial pressure as evaluated by clinical means.

Patients must not have cardiac pacemakers.

Patients must not be taking neuroleptics.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001923

Locations
United States, Maryland
National Institute of Neurological Disorders and Stroke (NINDS)    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information


Publications:

Study ID Numbers:   990022, 99-N-0022
First Received:   November 3, 1999
Last Updated:   March 3, 2008
ClinicalTrials.gov Identifier:   NCT00001923
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Pain  
Amputee  
Phantom Limb  
Amputation
Magnetic Stimulation
Phantom

Study placed in the following topic categories:
Pain
Phantom Limb

ClinicalTrials.gov processed this record on November 30, 2008




Links to all studies - primarily for crawlers